Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

InMed Pharmaceuticals Inc. - Common Shares (NQ: INM )

2.731 +0.041 (+1.52%)
Streaming Delayed Price Updated: 10:39 AM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about InMed Pharmaceuticals Inc. - Common Shares

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
InMed Names BayMedica VP Of Sales, Releases Q2 2022 Report
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. InMed Pharmaceuticals (NASDAQ: INM), a... 
Via Benzinga
InMed (NASDAQ: INM) Names BayMedica VP of Sales, Releases Q2 2022 Report
Via Investor Brand Network
Topics Intellectual Property Supply Chain
Exposures Intellectual Property Supply Chain
InMed Pharmaceuticals (INM): Generating Commercial Sales of CBC and CBT
LONDON, UK / ACCESSWIRE / February 16, 2022 / InMed Pharmaceuticals' (INM's) Q222 financial results reflect its evolution from a pure-play biotech firm to one with commercial sales to the health and... 
From Edison Investment Research Limited
Via AccessWire
Exposures Product Safety
InMed Pharmaceuticals' Issues Annual Shareholder Letter
InMed Pharmaceuticals (NASDAQ: 
Via Benzinga
InMed Positioned To Offer Rare Cannabinoid Manufacturing Technologies
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.... 
Via Benzinga
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Names BayMedica VP of Sales, Releases Q2 2022 Report
Via Investor Brand Network
Topics Intellectual Property Supply Chain
Exposures Intellectual Property Supply Chain
InMed (NASDAQ: INM) Positioned to Offer Rare Cannabinoid Manufacturing Technologies
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) in Unique Position to Offer Full Slate of Rare Cannabinoid Manufacturing Technologies
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) in Unique Position to Offer Full Slate of Rare Cannabinoid Manufacturing Technologies
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
InMed Pharmaceuticals To Release Q2 Financial Report, Update
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. InMed Pharmaceuticals (NASDAQ: INM), a... 
Via Benzinga
InMed Pharmaceuticals (NASDAQ: INM) to Release Q2 Financial Report, Update
Via Investor Brand Network
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Release Q2 Financial Report, Business Update
Via Investor Brand Network
InMed Pharmaceuticals Strengthens Leading Role In Rare Cannabinoid Market
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Cannabicitran is the first of four new rare cannabinoids InMed... 
Via Benzinga
InMed Pharmaceuticals (NASDAQ: INM) Strengthens Leading Role in Rare Cannabinoid Market
Via Investor Brand Network
InMed Pharmaceuticals Inc. (NASDAQ: INM) Strengthens Leading Role in Rare Cannabinoid Market Following New Product Launch, Key Acquisition
Via Investor Brand Network
InMed Pharmaceuticals Defining Value Of Rare Cannabinoids In Pharma Space
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
InMed Pharmaceuticals (NASDAQ: INM) Defining Value of Rare Cannabinoids in Pharma Space
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
CBDNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Blazing Trail in Defining Value of Rare Cannabinoids in Pharmaceutical Space
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
InMed (NASDAQ: INM) Gains Potential to Synthetically Produce Rare Cannabinoids at Scale
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Recent Access of Manufacturing Technologies Now Give It the Potential to Synthetically Produce Rare Cannabinoids at Large Scale, a Unique and Coveted Position in the Rapidly Developing Rare Cannabinoid Space
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
InMed Pharmaceuticals (NASDAQ: INM) Leveraging Growing Cannabinoid-Based Pharma Market
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
InMed Pharmaceuticals Inc. (NASDAQ: INM) Leveraging on the Growing Cannabinoid-Based Pharmaceuticals Market
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
InMed Pharmaceuticals Inc. (NASDAQ: INM) Leveraging on the Growing Cannabinoid-Based Pharmaceuticals Market
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
InMed Pharmaceuticals Expands Rare Cannabinoid Product Portfolio to Launch CBT
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. InMed Pharmaceuticals (NASDAQ: INM), a... 
Via Benzinga
InMed Pharmaceuticals (NASDAQ: INM) Expands Rare Cannabinoid Product Portfolio to Launch CBT
Via Investor Brand Network
Topics Supply Chain
Exposures Supply Chain
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Rare Cannabinoid Product Portfolio to Launch CBT
Via Investor Brand Network
Topics Supply Chain
Exposures Supply Chain
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Rare Cannabinoid Product Portfolio to Launch CBT
Via CannabisNewsWire
Topics Supply Chain
Exposures Supply Chain
4 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste... 
Via Benzinga
InMed Pharmaceuticals’ (NASDAQ: INM) Issues Annual Shareholder Letter
Via Investor Brand Network
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Annual Shareholder Letter Provides Company Highlights, 2022 Outlook
Via Investor Brand Network
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.